Ophthotech reported $49.75M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Alimera Sciences ALIM:US $ 16.58M 533K
Applied Genetic Technologies AGTC:US $ 13.58M 4.86M
Cytrx CYTR:US 1.29M 7.73M
Insmed INSM:US $ 153.54M 10.6M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Novartis NOVN:VX 10.86B 895M
Ophthotech OPHT:US $ 49.75M 15.08M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M